Convective therapies versus low-flux hemodialysis for chronic kidney failure: A meta-analysis of randomized controlled trials

Nephrology Dialysis Transplantation

Volumn 28, Issue 11, 2013, Pages 2859-2874

  Susantitaphong, Paweena ^a,b,c   Siribamrungwong, Monchai ^d   Jaber, Bertrand L ^a,b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d LERDSIN GENERAL HOSPITAL   (Thailand)

Author keywords

Convective therapy; Hemodiafiltration; Hemofiltration; High flux hemodialysis; Meta analysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA 2 MICROGLOBULIN; CREATININE; HOMOCYSTEINE; INTERLEUKIN 6; LEPTIN; PENTOSIDINE; PHOSPHATE; UREA;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CONVECTIVE THERAPY; HEMODIAFILTRATION; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; LOW FLUX HEMODIALYSIS; META ANALYSIS; MOLECULAR WEIGHT; NUTRITIONAL PARAMETERS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

CONVECTIVE THERAPY; HEMODIAFILTRATION; HEMOFILTRATION; HIGH-FLUX HEMODIALYSIS; META-ANALYSIS;

HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; REVIEW LITERATURE AS TOPIC;

EID: 84890051626     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft396     Document Type: Article

References (80)

1. Foley RN, Collins AJ. The USRDS: what you need to know about what it can and can't tell us about ESRD. Clin J Am Soc Nephrol 2013; 8: 845-851
2. Collins AJ, Foley RN, Gilbertson DT et al. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009; 4: S5-11
3. Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: association or cause and effect? Semin Dial 2006; 19: 129-135
4. Vanholder R, Glorieux G, De Smet R et al. New insights in uremic toxins. Kidney Int Suppl 2003; 84: S6-10.
5. Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transplant 2000; 15: 3-9
6. Canaud B, Bragg-Gresham JL, Marshall MR et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006; 69: 2087-2093
7. Thomas G, Jaber BL. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence. Sem in Dial 2009; 22: 610-614
8. Rabindranath KS, Strippoli GF, Daly C et al. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev 2006; 18: CD006258
9. Santoro A, Mancini E, Bolzani R et al. The effect of on-line highflux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 2008; 52: 507-518
10. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654
11. Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096
12. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
13. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12
14. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193-206
15. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
16. Teo KK, Basile C, Ulan RA et al. Comparison of hemodialysis and hypertonic hemodiafiltration on cardiac function [corrected]. Kidney Int 1987; 32: 399-407
17. Groll J, Hagemann J, Rohrich B et al. Atrial natriuretic peptide plasma levels during hemodialysis and hemofiltration in patients with end-stage renal disease. Int J Artif Organs 1989; 12: 284-288
18. Churchill DN, Bird DR, Taylor DW et al. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol 1992; 12: 412-418
19. Schiffl H, D'Agostini B, Held E. Removal of beta 2-microglobulin by hemodialysis and hemofiltration: a four year follow up. Biomater Artif Cells Immobilization Biotechnol 1992; 20: 1223-1232
20. Churchill DN, Taylor DW, Tomlinson CW et al. Effect of highflux hemodialysis on cardiac structure and function among patients with end-stage renal failure. Nephron 1993; 65: 573-577
21. Collins DM, Lambert MB, Tannenbaum JS et al. Tolerance of hemodialysis: a randomized prospective trial of high-flux versus conventional high-efficiency hemodialysis. J Am Soc Nephrol 1993; 4: 148-154
22. Blankestijn PJ, Vos PF, Rabelink TJ et al. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 1995; 5: 1703-1708
23. Bonomini M, Fiederling B, Bucciarelli T et al. A new polymethylmethacrylate membrane for hemodialysis. Int J Artif Organs 1996; 19: 232-239
24. Goldberg IJ, Kaufman AM, Lavarias VA et al. High flux dialysis membranes improve plasma lipoprotein profiles in patients with end-stage renal disease. Nephrol Dial Transplant 1996; 11: 104-107
25. Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996; 50: 1293-1302
26. Verzetti G, Navino C, Bolzani R et al. Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study. Nephrol Dial Transplant 1998; 13: 955-961
27. Eiselt J, Racek J, Opatrny K, Jr. The effect of hemodialysis and acetate-free biofiltration on anemia. Int J Artif Organs 2000; 23: 173-180
28. House AA, Wells GA, Donnelly JG et al. Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant 2000; 15: 1029-1034
29. Locatelli F, Andrulli S, Pecchini F et al. Effect of high-flux dialysis on the anaemia of haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1399-1409
30. Wizemann V, Lotz C, Techert F et al. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15: 43-48
31. Basile C, Giordano R, Montanaro A et al. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study. Nephrol Dial Transplant 2001; 16: 1914-1919
32. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019
33. Opatrny K, Jr, Reischig T, Vienken J et al. Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low-and high-flux biocompatible dialysis. Artif Organs 2002; 26: 181-188
34. Tuccillo S, Bellizzi V, Catapano F et al. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels]. G Ital Nefrol 2002; 19: 439-445
35. Cheung AK, Levin NW, Greene T et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14: 3251-3263
36. De Vriese AS, Langlois M, Bernard D et al. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2596-2600
37. Lin CL, Huang CC, Yu CC et al. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients. Am J Kidney Dis 2003; 42: 524-531
38. Pedrini LA, De Cristofaro V. On-line mixed hemodiafiltration with a feedback for ultrafiltration control: effect on middle-molecule removal. Kidney Int 2003; 64: 1505-1513
39. Richardson D, Lindley EJ, Bartlett C et al. A randomized, controlled study of the consequences of hemodialysis membrane composition on erythropoietic response. Am J Kidney Dis 2003; 42: 551-560
40. Beerenhout C, Dejagere T, van der Sande FM et al. Haemodynamics and electrolyte balance: a comparison between on-line pre-dilution haemofiltration and haemodialysis. Nephrol Dial Transplant 2004; 19: 2354-2359
41. Ayli D, Ayli M, Azak A et al. The effect of high-flux hemodialysis on renal anemia. J Nephrol 2004; 17: 701-706
42. Calzavara P, Malagoli A, Zagatti R. Comparative clinical study between standard hemodialysis, PHF (HDF on-line) and PHF AF (HDF on-line acetate free). G Ital Nefrol 2004; 21: S102-S105
43. Chiappini MG, Ammann T, Selvaggi G et al. Effects of different dialysis membranes and techniques on the nutritional status, morbidity and mortality of hemodialysis patients]. G Ital Nefrol 2004; 21: S190-S196
44. Cristofano C, Vernaglione L, Perniola MA et al. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis]. G Ital Nefrol 2004; 21: S197-S200
45. Klemm A, Franke C, Busch M et al. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites. Clin Nephrol 2004; 61: 191-197
46. Tessitore N, Lapolla A, Arico NC et al. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 2004; 17: 707-714
47. van Tellingen A, Grooteman MP, Schoorl M et al. Enhanced long-term reduction of plasma leptin concentrations by superflux polysulfone dialysers. Nephrol Dial Transplant 2004; 19: 1198-1203
48. Rocco MV, Dwyer JT, Larive B et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO study. Kidney Int 2004; 65: 2321-2334
49. Santacruz AC, Jimenez Dx, Guañuna MM. Comparative study between polysulfone and hemophan membranes. J Am Soc Nephrol 2005; 16: 842A
50. Ayli M, Ayli D, Azak A et al. The effect of high-flux hemodialysis on dialysis-associated amyloidosis. Ren Fail 2005; 27: 31-34
51. Beerenhout CH, Luik AJ, Jeuken-Mertens SG et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 2005; 20: 1155-1163
52. Karamperis N, Sloth E, Jensen JD. Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions. Kidney Int 2005; 67: 1601-1608
53. Santoro A, Mancini E, Bibiano L et al. Online convective therapies: results froma hemofiltration trial. Contrib Nephrol 2005; 149: 51-57
54. van Tellingen A, Schalkwijk CG, Teerlink T et al. Influence of different haemodialysis modalities on AGE peptide levels: intradialytic versus long-term results. Nephron Clin Pract 2005; 100: c1-c7
55. Bolasco P, Ghezzi PM, Ferrara R et al. New method for phosphate kinetics estimation during hemodialysis and on-line hemodiafiltration with endogenous reinfusion. Blood Purif 2006; 24: 301-308
56. Cheung AK, Rocco MV, Yan G et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555
57. Mandolfo S, Borlandelli S, Imbasciati E. Leptin and beta2-microglobulin kinetics with three different dialysis modalities. Int J Artif Organs 2006; 29: 949-955
58. Vaslaki L, Major L, Berta K et al. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006; 24: 163-173
59. Calo LA, Naso A, Carraro G et al. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrol Dial Transplant 2007; 22: 1413-1419
60. De Smet R, Dhondt A, Eloot S et al. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-proteinbound and protein-bound uraemic solutes. Nephrol Dial Transplant 2007; 22: 2006-2012
61. Karamperis N, Jensen D, Sloth E et al. Comparison of predilution hemodiafiltration and low-flux hemodialysis at temperature-controlled conditions using high calcium-ion concentration in the replacement and dialysis fluid. Clin Nephrol 2007; 67: 230-239
62. Traut M, Haufe CC, Eismann U et al. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Blood Purif 2007; 25: 432-440
63. Chu PL, Chiu YL, Lin JW et al. Effects of low-and high-flux dialyzers on oxidative stress and insulin resistance. Blood Purif 2008; 26: 213-220
64. Chen ZJ, Cao G, Tang WX et al. A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus. Clin Exp Dermatol 2009; 34: 679-683
65. Meert N, Beerenhout C, Schepers E et al. Evolution of proteinbound uraemic solutes during predilution haemofiltration. J Nephrol 2009; 22: 352-357
66. Gritters-van den Oever M, Grooteman MP, Bartels PC et al. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST. Nephrol Dial Transplant 2009; 24: 3461-3468
67. Eiselt J, Rajdl D, Racek J et al. Asymmetric dimethylarginine in hemodialysis, hemodiafiltration, and peritoneal dialysis. Artif Organs 2010; 34: 420-425
68. Li PK, Cheng YL, Leung CB et al. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial. Clin J Am Soc Nephrol 2010; 5: 652-658
69. Penne EL, van der Weerd NC, van den Dorpel MA et al. Shortterm effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010; 55: 77-87
70. Penne EL, van der Weerd NC, Blankestijn PJ et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 2010; 5: 80-86
71. Locatelli F, Altieri P, Andrulli S et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 2010; 21: 1798-1807
72. Alvestrand A, Ledebo I, Hagerman I et al. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study. Blood Purif 2011; 32: 21-29
73. Zhang DL, Liu J, Cui WY et al. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients. Ren Fail 2011; 33: 682-691
74. Pedrini LA, De Cristofaro V, Comelli M et al. Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 2011; 26: 2617-2624
75. Zhang D, Sun XF, Ma ZF et al. Effects of high-flux hemodialysis on plasma adrenomedullin and sustained hypotension in elderly hemodialysis patients. Chin Med J (Engl) 2011; 124: 907-910
76. Ohtake T, Oka M, Ishioka K et al. Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial 2012; 16: 181-188
77. Schneider A, Drechsler C, Krane V et al. The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study. Clin J Am Soc Nephrol 2012; 7: 52-59
78. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48: S2-90
79. Perna AF, Sepe I, Lanza D et al. Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies. J Ren Nutr 2012; 22: 191-194
80. Rambod M, Bross R, Zitterkoph J et al. Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53: 298-309